IMS Company Profiles - Report Buyer

IMS COM PANY PRO FILES NOVARTIS SUBSIDIARY LISTING
Novartis Subsidiary Listing
The fol low ing is a list of the main phar ma ceu ti cal sub sid iar ies and rep re sen ta tive of fices of the Novartis
group. The in for ma tion is taken from the IMSWorld pub li ca tion IMS Com pany Search. Sub sid iary de -
tails are ob tained us ing a va ri ety of in for ma tion sources, in clud ing send ing ques tion naires di rectly to the
com pany in each coun try, as well as in for ma tion pro vided by the com pa nies which are pro filed. The prod -
uct, ther a peu tic range and sales in for ma tion is taken from the IMS MI DAS database.
ALGERIA
NOVARTIS
Full Name: Novartis Pharma Ser vices AG, Bu -
reau de Li ai son Algerie
Street Ad dress: Bois des Cars 2, Lot No 215 Dely
Ibrahim, Route de Cheraga, Alger
Tel: +213 21 37 17 68
Fax: +213 21 37 17 92
Home Page: www.mea.novartis.com
De scrip tion: Li ai son of fice. Di vi sions in clude:
Novartis Con sumer Health.
Phar ma ceu ti cal Sales: US$ 100-110 mil lion
Prod ucts (% of Sales by Lead ing 5): 65-70%
Ther a peu tic Classes (% of Sales by Lead ing
5): 70-75%
Dose Forms (% of Sales by Lead ing 5):
95-100%
Prin ci pal Prod ucts:
TAREG (an gio ten sin-II an tag o nist plain)
COTAREG (an gio ten sin-II an tag o nist com bi na -
tion)
LOXEN (cal cium an tag o nist plain)
LESCOL (cho les terol/triglyceride reg u lat ing prep -
a ra tion)
FORADIL (B2-stim u lant)
Ther a peu tic Range:
renin-an gio ten sin sys tem agents 35%
cal cium an tag o nists 15%
antiasthma and COPD prod ucts 9%
lipid-reg u lat ing/antiatheroma prep a ra tions 9%
antiepileptics 6%
Lead ing Dose Forms:
coated tab lets 39%
cap sules 39%
tab lets 13%
liq uids 4%
in fu sions 3%
SANDOZ
Full Name: Gen er ale Pharmaceutique Ser vice,
Sandoz Mar ket ing
Street Ad dress: 119, Ter Rue Didouche Mourad,
16006 Alger
Tel: +213 21 51 57 01
Fax: +213 21 51 35 09
Phar ma ceu ti cal Sales: US$ 12-14 mil lion
Prod ucts (% of Sales by Lead ing 5): 45-50%
Ther a peu tic Classes (% of Sales by Lead ing
5): 85-90%
Dose Forms (% of Sales by Lead ing 5):
90-95%
Prin ci pal Prod ucts:
TIRLOR (an ti his ta mine sys temic)
OSPEN (pen i cil lin me dium/nar row spec trum)
UROBACID (uri nary anti-in fec tive/an ti sep tic)
OSPEXIN (cephalosporin)
DOTUR (tet ra cy cline/com bi na tion)
Ther a peu tic Range:
antibacterials sys temic 54%
an ti his ta mines sys temic 13%
urologicals 10%
cal cium an tag o nists 7%
vi ta mins 5%
Lead ing Dose Forms:
tab lets 39%
coated tab lets 16%
cap sules 15%
vi als 13%
liq uids 12%
ARGENTINA
HEXAL
Full Name: HEXAL Ar gen tina S.A.
Street Ad dress: Paseo Co lon 221, Piso 7, 1063
Bue nos Ai res
Tel: +54 11 4334-2080
Fax: +54 11 4334-2084
Email: info@hexal.com.ar
Home Page: www.hexal.com.ar
De scrip tion: Es tab lished 2001.
Con tacts (Pharm): Chair man: Dr Erich Brun -
ner; Gen eral Con tact: Soledad Pasman
© 2009 IMS Health In cor po rated or its af fil i ates Page 147